BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 2128373)

  • 1. Involvement of the nigral output pathways in the inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat.
    Depaulis A; Vergnes M; Liu Z; Kempf E; Marescaux C
    Neuroscience; 1990; 39(2):339-49. PubMed ID: 2128373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat.
    Depaulis A
    J Neural Transm Suppl; 1992; 35():125-39. PubMed ID: 1324977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that activation of GABA receptors in the substantia nigra suppresses spontaneous spike-and-wave discharges in the rat.
    Depaulis A; Vergnes M; Marescaux C; Lannes B; Warter JM
    Brain Res; 1988 May; 448(1):20-9. PubMed ID: 2839269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of spontaneous generalized non-convulsive seizures in the rat by microinjection of GABA antagonists into the superior colliculus.
    Depaulis A; Liu Z; Vergnes M; Marescaux C; Micheletti G; Warter JM
    Epilepsy Res; 1990 Apr; 5(3):192-8. PubMed ID: 2384075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the substantia nigra suppresses absences and clonic seizures in audiogenic rats, but not tonic seizures: evidence for seizure specificity of the nigral control.
    Deransart C; Lê-Pham BT; Hirsch E; Marescaux C; Depaulis A
    Neuroscience; 2001; 105(1):203-11. PubMed ID: 11483312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GABAergic nigro-collicular pathway is not involved in the inhibitory control of audiogenic seizures in the rat.
    Depaulis A; Marescaux C; Liu Z; Vergnes M
    Neurosci Lett; 1990 Apr; 111(3):269-74. PubMed ID: 2336202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents.
    Depaulis A; Snead OC; Marescaux C; Vergnes M
    Brain Res; 1989 Sep; 498(1):64-72. PubMed ID: 2551457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of the parafascicular nucleus of the thalamus in the control of epileptic seizures by the superior colliculus.
    Nail-Boucherie K; Lê-Pham BT; Gobaille S; Maitre M; Aunis D; Depaulis A
    Epilepsia; 2005 Jan; 46(1):141-5. PubMed ID: 15660780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of proconvulsant action of GABA depletion in substantia nigra in several seizure models.
    Maggio R; Sohn E; Gale K
    Brain Res; 1991 Apr; 547(1):1-6. PubMed ID: 1650283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the inhibitory GABAA receptor agonist muscimol.
    Savaki HE; Raos VC; Dermon CR
    Neuroscience; 1992 Oct; 50(4):781-94. PubMed ID: 1333060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAergic and glycinergic mechanisms within the substantia nigra: pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters.
    Arnt J; Scheel-Krüger J
    Psychopharmacology (Berl); 1979 Apr; 62(3):267-77. PubMed ID: 37544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia nigra-mediated anticonvulsant actions: role of nigral output pathways.
    Garant DS; Gale K
    Exp Neurol; 1987 Jul; 97(1):143-59. PubMed ID: 3582559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the substantia nigra in GABA-mediated anticonvulsant actions.
    Gale K
    Adv Neurol; 1986; 44():343-64. PubMed ID: 3010676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral alterations in local cerebral glucose utilization following intranigral application of the GABAergic agonist muscimol.
    Dermon CR; Pizarro P; Georgopoulos P; Savaki HE
    J Neurosci; 1990 Sep; 10(9):2861-78. PubMed ID: 2398365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turning behaviour induced by injection of muscimol or picrotoxin into the substantia nigra demonstrates dual GABA components.
    Reavill C; Jenner P; Leigh N; Marsden CD
    Neurosci Lett; 1979 May; 12(2-3):323-8. PubMed ID: 460728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [GABAergic mechanisms in generalized epilepsies: the neuroanatomical dimension].
    Depaulis A; Deransart C; Vergnes M; Marescaux C
    Rev Neurol (Paris); 1997; 153 Suppl 1():S8-13. PubMed ID: 9686242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
    Cobb WS; Abercrombie ED
    Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat.
    Liu Z; Vergnes M; Depaulis A; Marescaux C
    Brain Res; 1991 Apr; 545(1-2):1-7. PubMed ID: 1650272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of the telencephalon spares turning induced by injection of GABA agonists and antagonists into the substantia nigra.
    Papadopoulos G; Huston JP
    Behav Brain Res; 1980 Feb; 1(1):25-38. PubMed ID: 7197156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.